Frida Isernia

Frida Isernia has extensive experience in the pharmaceutical industry, currently serving as an Informatore Medico Scientifico at ABIOGEN PHARMA S.P.A. since January 2014, focusing on multiple therapeutic areas including Metabolism, Pain, Pneumology, Dermatology, Diabetology, Pediatrics, Orthopedics, Physical Therapy, and Infiltrative Therapy. Prior to this role, Frida Isernia worked at Daiichi Sankyo from June 2011 to July 2013 in the Cardiovascular area, and held positions at GlaxoSmithKline and Pfizer, specializing in Rare Diseases and Cardiometabolic and Urological fields respectively. Frida Isernia began their career at Sanofi, where responsibilities included Infection Control, Thrombosis, and Rare Diseases. Frida Isernia holds a degree in Scienze Geologiche from the Università degli Studi di Parma.